Education
About Us
Working with TipRanks
Follow Us
Zoono Group Limited (AU:ZNO)
ASX:ZNO
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)153.26K
Market Cap
AU$26.81M
Enterprise ValueAU$27.71M
Total Cash (Recent Filing)AU$47.30K
Total Debt (Recent Filing)AU$544.56K
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageThe company’s low reported debt load (debt-to-equity ~0.18) materially reduces near-term solvency risk and interest burden. Over 2–6 months this provides financial flexibility to execute operational fixes or sales expansion without immediate refinancing pressure, supporting stability while profitability recovers.
Positive Revenue Growth TrendConsistent top-line growth (mid-teens year-over-year) signals underlying demand for antimicrobial products and supports scale economics if maintained. Over the medium term this trend gives management runway to improve mix, negotiate better channel terms, and potentially recover margins as fixed costs are spread across higher volumes.
Repeatable, Consumable Product Business ModelSelling consumable antimicrobial products through multiple channels creates recurring purchase potential and distribution leverage. Institutional and retail channels can yield repeat orders and steady demand, supporting predictable revenue streams and scalability over months if distribution relationships are maintained and product efficacy remains proven.
Bears Say
Negative Profitability And Gross LossesDeep negative gross profit and an extreme net margin (about -314%) indicate structural pricing or cost issues that undermine sustainable earnings. Without margin recovery, revenue growth alone cannot restore profitability, eroding long-term viability and making operational turnaround necessary to avoid persistent losses and further capital erosion.
Persistent Negative Cash GenerationConsistent operating cash outflows and declining free cash flow mean the business cannot self-fund growth or cover losses. Over several months this raises financing and dilution risk, restricts investment in distribution or product development, and pressures liquidity unless external capital or sustained margin improvement occurs.
Material Equity ErosionA drastic decline in shareholder equity reduces the company’s ability to absorb shocks and limits borrowing capacity. Over the medium term this weakened capital base increases dependence on external funding, raises dilution risk for shareholders, and reduces strategic flexibility to pursue growth or weather prolonged operating shortfalls.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$26.81M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Aug 20, 2026 which is in 178 days.
How were Zoono Group Limited’s earnings last quarter?
Currently, no data Available
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.18%
12-Months-Change
Fundamentals
Return on Equity
-77.92%
Trailing 12-Months
Asset Growth
-34.64%
Trailing 12-Months
Company Description
Zoono Group Limited
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.
Technical Analysis
Skin Elements Limited
―
Food Revolution Group Ltd.
―
Fiji Kava Limited
―
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---